RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Recursion Pharmaceuticals Stock

Recursion Pharmaceuticals P/S 2024

Recursion Pharmaceuticals P/S

26.58

Ticker

RXRX

ISIN

US75629V1044

As of Nov 19, 2024, Recursion Pharmaceuticals's P/S ratio stood at 26.58, a -35% change from the 40.89 P/S ratio recorded in the previous year.

The Recursion Pharmaceuticals P/S history

Recursion Pharmaceuticals Aktienanalyse

What does Recursion Pharmaceuticals do?

Recursion Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Recursion Pharmaceuticals's P/S Ratio

Recursion Pharmaceuticals's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Recursion Pharmaceuticals's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Recursion Pharmaceuticals's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Recursion Pharmaceuticals’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Recursion Pharmaceuticals stock

What is the price-to-earnings ratio of Recursion Pharmaceuticals?

The price-earnings ratio of Recursion Pharmaceuticals is currently 26.58.

How has the price-earnings ratio of Recursion Pharmaceuticals changed compared to last year?

The price-to-earnings ratio of Recursion Pharmaceuticals has increased by -35% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Recursion Pharmaceuticals high compared to other companies?

Yes, the price-to-earnings ratio of Recursion Pharmaceuticals is high compared to other companies.

How does an increase in the price-earnings ratio of Recursion Pharmaceuticals affect the company?

An increase in the price-earnings ratio of Recursion Pharmaceuticals would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Recursion Pharmaceuticals affect the company?

A decrease in the price-earnings ratio of Recursion Pharmaceuticals would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Recursion Pharmaceuticals?

Some factors that influence the price-earnings ratio of Recursion Pharmaceuticals are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Recursion Pharmaceuticals pay?

Over the past 12 months, Recursion Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Recursion Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Recursion Pharmaceuticals?

The current dividend yield of Recursion Pharmaceuticals is .

When does Recursion Pharmaceuticals pay dividends?

Recursion Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Recursion Pharmaceuticals?

Recursion Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Recursion Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Recursion Pharmaceuticals located?

Recursion Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Recursion Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Recursion Pharmaceuticals from 11/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/19/2024.

When did Recursion Pharmaceuticals pay the last dividend?

The last dividend was paid out on 11/19/2024.

What was the dividend of Recursion Pharmaceuticals in the year 2023?

In the year 2023, Recursion Pharmaceuticals distributed 0 USD as dividends.

In which currency does Recursion Pharmaceuticals pay out the dividend?

The dividends of Recursion Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Recursion Pharmaceuticals

Our stock analysis for Recursion Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Recursion Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.